<DOC>
	<DOCNO>NCT01101204</DOCNO>
	<brief_summary>The study plan show whether combined hypolipemic antidiabetic therapy various daily dosage influence fast plasma glucose , insulin sensitivity proinflammatory cytokine diabetic dyslipidemic subject .</brief_summary>
	<brief_title>The Effects Hypolipemic Antidiabetic Treatment Cytokines</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Fenofibrate</mesh_term>
	<criteria>Age ( 3564yr ) Primary hyperlipidemia ( Total cholesterol &gt; 200mg/dl , Triglycerides &gt; 150mg/dl ) Type 2 Diabetes For woman : Menopause ( &gt; 12 month ) Post hysterectomy Mechanical contraception Obtained informed consent Secondary hyperlipidemia Morbid obesity ( BMI &gt; 40kg/m2 ) Alcohol drug abuse Acute chronic inflammation Congestive Heart Failure ( NYHA III IV ) Unstable Ischaemic Heart Disease Moderate severe hypertension Cancer le 5 year Chronic kidney disease ( stage IIIV ) Liver failure Oral contraception Not compliant patient Laboratory result : alanine transferase ( &gt; 3xULN ) creatine kinase ( &gt; 5xULN ) haemoglobin ( &lt; 10/dl ) PLT ( &lt; 100G/l ) WBC ( &lt; 3,5G/l &gt; 10G/l )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>